Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer (Diagnosis)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02673151
What this trial is testing

68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

Who this might be right for
Prostate AdenocarcinomaPSA FailureRecurrent Prostate Carcinoma
Andrei Iagaru 61
Not applicableUnknownNCT05069467
What this trial is testing

Acupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL)

Who this might be right for
Hot FlashesProstate CancerAcupuncture
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 120
Testing effectiveness (Phase 2)Ended earlyNCT00861471
What this trial is testing

Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 24
Not applicableStudy completedNCT05970471
What this trial is testing

Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital

Who this might be right for
Preference, PatientPharmacist-Patient RelationsCaregiver+1 more
Centre Hospitalier Universitaire de Besancon 167
Not applicableLooking for participantsNCT05435495
What this trial is testing

Mechanisms of Resistance to PSMA Radioligand Therapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 125
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Early research (Phase 1)Ended earlyNCT04033328
What this trial is testing

Study of ORIC-101 in Combination With Enzalutamide

Who this might be right for
Prostatic Neoplasms
ORIC Pharmaceuticals 41
Not applicableUnknownNCT03968692
What this trial is testing

Adequacy of Prostate-Specific Antigen (PSA) Requests

Who this might be right for
Prostate-Specific Antigen
Universidad Miguel Hernandez de Elche 1,410
Not applicableStudy completedNCT04902144
What this trial is testing

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Who this might be right for
Breast CarcinomaColon CarcinomaMalignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 6
Not applicableUnknownNCT05460312
What this trial is testing

Protein Kinase A in Prostate Cancer Tissue.

Who this might be right for
Prostate NeoplasmInflammationBenign Hyperplasia of Prostate
Ziv Hospital 100
Not applicableLooking for participantsNCT06700057
What this trial is testing

Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.

Who this might be right for
Prostate CancerMetastasis
Institut Bergonié 50
Large-scale testing (Phase 3)Study completedNCT00002881
What this trial is testing

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Not applicableLooking for participantsNCT07672119
What this trial is testing

Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide

Who this might be right for
Prostate Cancer
Bayer 3,000
Testing effectiveness (Phase 2)Study completedNCT01748500
What this trial is testing

Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 21
Testing effectiveness (Phase 2)Ended earlyNCT03763851
What this trial is testing

Cannabis Oil and Radiation Therapy for the Management of Pain

Who this might be right for
Metastatic Prostate CancerLung CancerBreast Cancer
Tetra Bio-Pharma 100
Early research (Phase 1)Study completedNCT00559429
What this trial is testing

Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 13
Testing effectiveness (Phase 2)Study completedNCT01240629
What this trial is testing

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Prostate CancerHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
University of Southern California 43
Testing effectiveness (Phase 2)Looking for participantsNCT04573231
What this trial is testing

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer
University of Wisconsin, Madison 13
Not applicableStudy completedNCT06131853
What this trial is testing

Kinesiophobia in Prostate Cancer

Who this might be right for
Prostate CancerKinesiophobiaPhysical Inactivity
Selcuk University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06457919
What this trial is testing

Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 50
Next Page